reviewTop 1% cited

Chemotherapy and the war on cancer

Nature reviews. Cancer · 2005 · Vol. 5(1) · pp. 65–72

Bruce A. Chabner✉(Massachusetts General Hospital)Thomas G. Roberts(Harvard University)

Lung Cancer Treatments and Mutations Cancer Genomics and Diagnostics Cancer Treatment and PharmacologyLiberian dollarChemotherapyCancer chemotherapyGovernment (linguistics)MedicineCancerIntensive care medicineCancer drugsOncologyPolitical science

MeSH terms

Antineoplastic AgentsHumansNeoplasmsUnited StatesHistory, 20th CenturyHistory, 21st Century

Citations

2,077

FWCI

23.36

field-weighted impact

References

Percentile

100%

vs. same field & year

Citations per year

Cited by

3D tumor spheroids as in vitro models to mimic in vivo human solid tumors resistance to therapeutic drugs

Biotechnology and Bioengineering · 2018 · 676 citations

Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile

Science Translational Medicine · 2012 · 1,113 citations

U.S. FDA Approved Drugs from 2015–June 2020: A Perspective

Journal of Medicinal Chemistry · 2021 · 714 citations

Cancer Cell Lines Are Useful Model Systems for Medical Research

Cancers · 2019 · 322 citations

Ligand-Directed Active Tumor-Targeting Polymeric Nanoparticles for Cancer Chemotherapy

Biomacromolecules · 2014 · 527 citations

Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium

Frontiers in Pharmacology · 2018 · 869 citations

Molecular targeted therapy: Treating cancer with specificity

European Journal of Pharmacology · 2018 · 1,045 citations

The PI3K–AKT network at the interface of oncogenic signalling and cancer metabolism

Nature reviews. Cancer · 2019 · 2,067 citations

References

Tumor Angiogenesis: Therapeutic Implications

New England Journal of Medicine · 1971 · 10,087 citations

Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials

British Journal of Cancer · 2001 · 854 citations

Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia

Cancer Cell · 2002 · 1,620 citations

The Hallmarks of Cancer

Cell · 2000 · 28,385 citations

Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib

New England Journal of Medicine · 2004 · 11,455 citations

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

Journal of Immunological Methods · 1983 · 55,054 citations

Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer

New England Journal of Medicine · 2004 · 10,930 citations

<i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy

Science · 2004 · 9,380 citations

Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.